Bristol Myers Squibb Provides Update on CheckMate -914 Trial Evaluating Opdivo Plus Yervoy as Adjuvant Treatment of Localized Renal Cell Carcinoma Pharmaceutical Investing
RINVOQ® Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis Pharmaceutical Investing
Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation Pharmaceutical Investing
Biktarvy® Demonstrates High Efficacy for a Broad Range of People Initiating Treatment for HIV, Including Those With HBV Coinfection Pharmaceutical Investing
Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9 Pharmaceutical Investing
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Crohn's Disease Pharmaceutical Investing
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference
Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis
